Exploration of Copper-Cysteamine Nanoparticles as a New Type of Agents for Antimicrobial Photodynamic Inactivation

Liyi Huang, Lun Ma, Weijun Xuan, Xiumei Zhen, Han Zheng, Wei Chen, Michael R. Hamblin

Journal of Biomedical Nanotechnology · 2019 · 32 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis ) and gram-negative bacteria ( Escherichia coli and Acinetobacter baumannii ), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.

References

18